| 臺北醫學大學 |
2013 |
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma
|
Chung, CJ;Pu, YS;Shiue, HS;Lee, HL;Lin, P;Yang, YH;Su, CT;Hsueh, YM |
| 臺北醫學大學 |
2013 |
The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype
|
Chung, CJ;Huang, CY;Pu, YS;Shiue, HS;Su, CT;Hsueh, YM |
| 國家衛生研究院 |
2012-12 |
A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression
|
Lee, YR;Yuan, WC;Huang, SF;Lin, YM;Chen, TY;Chung, HC;Tsai, CH;Chen, HY;Chiang, CT;Lai, CK;Lu, LT;Chen, CH;Gu, DL;Pu, YS;Jou, YS;Lu, K;Hsiao, PW;Shih, HM;Chen, RH |
| 國家衛生研究院 |
2012-11 |
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma
|
Wu, CC;Su, CT;Lee, HL;Chung, CJ;Huang, CY;Pu, YS;Lin, P;Hsueh, YM |
| 國家衛生研究院 |
2011-08 |
A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression
|
Yuan, WC;Lee, YR;Huang, SF;Lin, YM;Chen, TY;Chung, HC;Tsai, CH;Chen, HY;Chiang, CT;Lai, CK;Lu, LT;Chen, CH;Gu, DL;Pu, YS;Jou, YS;Lu, KP;Hsiao, PW;Shih, HM;Chen, RH |
| 中國醫藥大學 |
2011-08 |
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy
|
(Huang SP)*; 鮑柏穎(Bo-Ying Bao); (Wu MT); (Choueiri TK); (Goggins WB); (Huang CY); (Pu YS); (Yu CC); (Huang CH) |
| 國家衛生研究院 |
2011-04 |
Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk
|
Chung, CJ;Lee, HL;Yang, HY;Lin, P;Pu, YS;Shiue, HS;Su, CT;Hsueh, YM |
| 中國醫藥大學 |
2011-02 |
Polymorphisms inside MicroRNAs and MicroRNA Target Sites Predict Clinical Outcomes in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy.
|
鮑柏穎(Bo-Ying Bao); (Pao JB); (Huang CN); (Pu YS); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 莊聲宏(Shin-Hun Juang); 陳璐敏(Lu-Min Chen); (Hsieh CJ); (Huang SP)* |
| 高雄醫學大學 |
2011 |
Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium.
|
楊俊毓; Wu, CC;Pu, YS;Wu, HC;Yang, CY;Chen, YC |
| 中國醫藥大學 |
2011 |
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
|
鮑柏穎(Bo-Ying Bao); (Pao JB); (Huang CN); (Pu YS); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 陳璐敏(Lu-Min Chen); (Ting WC); (Hsieh CJ); (Huang SP)* |
| 中國醫藥大學 |
2011 |
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy
|
(Huang CN); (Huang SP); (Pao JB); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 莊聲宏(Shin-Hun Juang); 吳玢玢(Wu Ping-Ping); (Pu YS); (Hsieh CJ); 鮑柏穎(Bo-Ying Bao)* |
| 中國醫藥大學 |
2011 |
Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
|
(Huang SP)*; 鮑柏穎(Bo-Ying Bao); (Wu MT); (Choueiri TK); (Goggins WB); (Liu CC); (Huang CY); (Pu YS); (Yu CC); (Wu TT); (Huang CN); (Huang CH); (Wu WJ) |
| 中山醫學大學 |
2010 |
Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells.
|
Huang, CY; Chen, JY; Wu, JE; Pu, YS; Liu, GY; Pan, MH; Huang, YT; Huang, AM; Hwang, CC; Chung, SJ; Hour, TC |
| 高雄醫學大學 |
2010 |
靈芝萃取物協同增強抗癌藥物毒殺具抗藥性之泌尿上皮癌細胞
|
黃昭淵;陳逸夫;吳嘉恩;蒲永孝;劉光耀;潘敏雄;黃胤塘;黃阿梅;黃啟清;侯自銓 ; Huang CY;Chen Jeff YF;Wu JE;Pu YS;Liu GY;Pan MH;Huang YT;Huang AM;Hwang CC;Chung SJ;Hour TC |
| 高雄醫學大學 |
2010 |
Terpenoids透過ROS誘導細胞週期停滯及凋亡
|
黃阿梅;涂皇堯;侯自銓;蒲永孝;林忠男 ; Chen HL;Lin KW;Huang AM;Tu HY;Wei BL;Hour TC;Yen MH;Pu YS;Lin CN |
| 義守大學 |
2009-12 |
Cadmium burden and the risk and phenotype of prostate cancer
|
Chen YC; Pu YS; Wu HC;Tony T Wu;Lai MK;Yang CY;Sung FC |
| 中國醫藥大學 |
2009-12 |
Cadmium burden and the risk and phenotype of prostate cancer
|
(Chen YC); (Pu YS); (Wu HC); (Wu TT); (Lai MK); (Yang CY); 宋鴻樟(Fung-Chang Sung)* |
| 國家衛生研究院 |
2009-01 |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and n(7)-methylguanine in urothelial carcinoma patients [Erratum: Cancer Epidemiology Biomarkers & Prevention. 2008 Dec;17(12):3390-3395.]
|
Lee, HL;Hsueh, YM;Chung, CJ;Pu, YS;Chang, LW;Hsieh, DPH;Liou, SH;Lin, P |
| 臺北醫學大學 |
2009 |
Arsenic Methylation Capability; Myeloperoxidase (MPO) and sulfortransferase (SULT 1A1) Genetic Polymorphisms; and the Stage and Grade of Urothelial Carcinoma
|
薛玉梅; Huang Steven K; Chiu Allen WH; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM |
| 臺北醫學大學 |
2009 |
Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in Taiwan
|
薛玉梅; Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS |
| 臺北醫學大學 |
2009 |
Clinical Pathological characteristics and survival outcome of arsenic-related bladder cancer in Taiwan.
|
邱弘毅; Chen CH; Chiou HY; Hsieh YM; Chen CJ; Yu HJ; Pu YS |
| 中山醫學大學 |
2009 |
Downregulation of ABCD1 in human renal cell carcinoma.
|
Hour, TC; Kuo, YZ; Liu, GY; Kang, WY; Huang, CY; Tsai, YC; Wu, WJ; Huang, SP; Pu, YS |
| 高雄醫學大學 |
2009 |
Cadmium burden and the risk and phenotype of prostate cancer.
|
楊俊毓; Chen, YC;Pu, YS;Wu, HC;Wu, TT;Lai, MK;Yang, CY; , Sung FC |
| 國家衛生研究院 |
2008-12-01 |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients
|
Lee, HL;Hsueh, YM;Chung, CJ;Pu, YS;Chang, LW;Hsieh, DPH;Liou, SH;Lin, P |
| 國立臺灣大學 |
2008-11 |
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
|
Lin, CC; Pu, YS; Hsu, CH; Keng, HY; Cheng, AL; Yang, CH |
